TILT Holdings (TLLTF) Depreciation and Depletion (2021 - 2025)
TILT Holdings (TLLTF) reported Depreciation and Depletion of $127000.0 for Q2 2025, up 28.28% on a YoY basis from $99000.0 in Q2 2024, and down 89.23% quarter-over-quarter from $1.2 million in Q1 2025.
TILT Holdings (TLLTF) Depreciation and Depletion (2021 - 2025) Analysis & Trends
TILT Holdings has reported Depreciation and Depletion for 5 years, with the latest figure at $127000.0 in Q2 2025.
- For the quarter ending Q2 2025, Depreciation and Depletion rose 28.28% year-over-year to $127000.0; the trailing twelve-month figure through Jun 2025 stood at $3.7 million (down 22.85% YoY), and the FY2024 full-year result was $5.5 million, down 27.82% from the prior year.
- Depreciation and Depletion for Q2 2025 stood at $127000.0, down from $1.2 million in the prior quarter.
- The five-year high for Depreciation and Depletion was $2.5 million in Q2 2023, with the low at $99000.0 in Q2 2024.
- Historically, Depreciation and Depletion has averaged $1.6 million across 5 years, with a median of $1.6 million in 2023.
- Annual changes were most pronounced in 2022 — Depreciation and Depletion jumped 35.46% — and 2024, when it sank 96.01%.
- TILT Holdings' Depreciation and Depletion stood at $2.0 million in 2021, then gained by 9.48% to $2.2 million in 2022, then dropped by 26.66% to $1.6 million in 2023, then retreated by 23.92% to $1.2 million in 2024, then tumbled by 89.52% to $127000.0 in 2025.
- The last three Depreciation and Depletion figures came in at $127000.0 (Q2 2025), $1.2 million (Q1 2025), and $1.2 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 36.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 21.60 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 7.20 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 28.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | TILT Holdings | - | - | 1.82 Mn | 127,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 127,000.00 |
| Jun 30, 2025 | 127,000.00 |
| Mar 31, 2025 | 1.18 Mn |
| Mar 31, 2025 | 1.18 Mn |
| Dec 31, 2024 | 1.21 Mn |
| Dec 31, 2024 | 1.21 Mn |
| Sep 30, 2024 | 1.22 Mn |
| Sep 30, 2024 | 1.22 Mn |
| Jun 30, 2024 | 99,000.00 |
| Jun 30, 2024 | 99,000.00 |
| Mar 31, 2024 | 1.55 Mn |
| Mar 31, 2024 | 1.55 Mn |
| Dec 31, 2023 | 1.59 Mn |
| Dec 31, 2023 | 1.59 Mn |
| Sep 30, 2023 | 1.60 Mn |
| Sep 30, 2023 | 1.60 Mn |
| Jun 30, 2023 | 2.48 Mn |
| Jun 30, 2023 | 2.48 Mn |
| Mar 31, 2023 | 1.98 Mn |
| Mar 31, 2023 | 1.98 Mn |